Research programme: armed therapeutic viruses - Onyx
Alternative Names: Armed therapeutic viruses - Onyx; ATVLatest Information Update: 24 Oct 2021
At a glance
- Originator EPTTCO; Onyx Pharmaceuticals
- Developer Onyx Pharmaceuticals; Pfizer; Proacta Therapeutics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 10 May 2004 Discontinued - Preclinical for Cancer in United Kingdom (unspecified route)
- 10 May 2004 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 10 May 2004 Discontinued - Preclinical for Cancer in New Zealand (unspecified route)